secwatch.observer — SEC 8-K summary
======================================

Issuer:     Novo Integrated Sciences, Inc. (—)
CIK:        0001138978
Form:       8-K
Filed at:   2025-05-06T23:59:59+00:00
Accession:  0001641172-25-008853
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Novo Integrated extends CEO resignation to May 31; board member Pope resigns
----------------------------------------------------------------------------

- CEO Robert Mattacchione's resignation extended to no later than May 31, 2025 from prior April 30 deadline.
- Mattacchione will remain Chairman of the Board and Chairman of subsidiary Novo Healthnet Ltd after CEO departure.
- Board member Michael Pope resigned effective May 1, 2025; resignation not due to any disagreement with the company.
- No permanent CEO replacement announced; search process not disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1138978/000164117225008853/0001641172-25-008853-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1138978/000164117225008853/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-008853

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer